PET-CT scanner device market has been witnessing a significant growth over the past few years owing to increasing prevalence of cancer and other chronic diseases globally. PET-CT scanner combines two medical imaging techniques- positron emission tomography and X-ray computed tomography into a single device, allowing physicians to obtain functional and anatomical information simultaneously. Some of the key advantages of PET-CT over other imaging modalities include better detection of tumors, evaluation of cancer treatment response and localization of sites of metastases. Growing geriatric population prone to various forms of cancers as well as increasing awareness about early disease diagnosis have been fueling the demand for PET-CT scanners across major healthcare markets. However, high equipment and radiotracer production costs pose a major barrier to widespread adoption.
Market Dynamics:
The global PET-CT scanner device market is driven by rising cancer incidence, increasing public-private investments to enhance diagnostic imaging facilities and favorable reimbursement scenario for PET-CT procedures in developed nations. As per WHO, cancer burden is expected to surge by over 70% in next two decades. This widespread cancer epidemic is anticipated to augment the market growth during the forecast period. However, market potential can be negatively impacted by certain factors such as radiation exposure risks, shortage of trained professionals and high monetary investments required for setting up PET-CT production units. Market players could gain new opportunities from emerging therapeutic applications of PET-CT including treatment monitoring and drug development. Technology advancements in radiotracer development, hybrid scanner design and image reconstruction software are also expected to open new revenue streams for market participants going forward.
Key features of the study:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook